Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024       10,829 1,646        
Beginning balance at Dec. 31, 2024 $ 244,714     $ 1 $ 0 $ 327,964 $ (632) $ (31,324) $ (51,295)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (14,946) $ (12,985) $ (1,961)         (14,946)  
Exercise of stock options (in shares)       15          
Exercise of stock options 122         122      
Restricted stock vesting, net of shares withheld (in shares)       348          
Restricted stock vesting, net of shares withheld (1,930)         (1,930)      
Stock-based compensation 12,343         12,343      
Repurchase of common stock (in shares)       (229)          
Repurchase of common stock (3,499)               (3,499)
Other comprehensive income (loss) 2,120           2,120    
Ending balance (in shares) at Sep. 30, 2025       10,963 1,646        
Ending balance at Sep. 30, 2025 238,924     $ 1 $ 0 338,499 1,488 (46,270) (54,794)
Beginning balance (in shares) at Jun. 30, 2025       10,878 1,646        
Beginning balance at Jun. 30, 2025 245,290     $ 1 $ 0 335,687 1,548 (37,152) (54,794)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (9,118) $ (7,924) $ (1,194)         (9,118)  
Exercise of stock options (in shares)       5          
Restricted stock vesting, net of shares withheld (in shares)       80          
Restricted stock vesting, net of shares withheld (379)         (379)      
Stock-based compensation 3,191         3,191      
Other comprehensive income (loss) (60)           (60)    
Ending balance (in shares) at Sep. 30, 2025       10,963 1,646        
Ending balance at Sep. 30, 2025 238,924     $ 1 $ 0 338,499 1,488 (46,270) (54,794)
Beginning balance (in shares) at Dec. 31, 2025   11,008 1,646 11,008 1,646        
Beginning balance at Dec. 31, 2025 227,866     $ 1 $ 0 340,816 1,806 (59,963) (54,794)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (34,989) $ (30,391) $ (4,598)         (34,989)  
Exercise of stock options (in shares)       2          
Restricted stock vesting, net of shares withheld (in shares)       347          
Restricted stock vesting, net of shares withheld (593)         (593)      
Stock-based compensation 7,091         7,091      
Repurchase of common stock (in shares)       (920)          
Repurchase of common stock (5,795)               (5,795)
Forfeiture of common stock (in shares)       (90)          
Other comprehensive income (loss) 677           677    
Ending balance (in shares) at Sep. 30, 2026   10,347 1,646 10,347 1,646        
Ending balance at Sep. 30, 2026 194,257     $ 1 $ 0 347,314 2,483 (94,952) (60,589)
Beginning balance (in shares) at Jun. 30, 2026       10,924 1,646        
Beginning balance at Jun. 30, 2026 207,695     $ 1 $ 0 345,263 2,695 (83,913) (56,351)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (11,039) $ (9,530) $ (1,509)         (11,039)  
Restricted stock vesting, net of shares withheld (in shares)       58          
Restricted stock vesting, net of shares withheld (60)         (60)      
Stock-based compensation 2,111         2,111      
Repurchase of common stock (in shares)       (635)          
Repurchase of common stock (4,238) $ (1,100)             (4,238)
Other comprehensive income (loss) (212)           (212)    
Ending balance (in shares) at Sep. 30, 2026   10,347 1,646 10,347 1,646        
Ending balance at Sep. 30, 2026 $ 194,257     $ 1 $ 0 $ 347,314 $ 2,483 $ (94,952) $ (60,589)